Press Releases

Calidi is at the forefront of the genetic medicine revolution in cancer and other indications

Read the Latest

Press Release

Calidi Biotherapeutics Presents New Data on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting and Holds Its First Investor Day at SITC

Read More
Press Release
Calidi Biotherapeutics Announces Appointment of Jim Schoeneck, Accomplished Biotech Executive, to Board of Directors
SAN DIEGO, CA – (BUSINESS WIRE) – Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
 
Press Release
Calidi Biotherapeutics Announces Two Abstracts Accepted for Presentation at AACR 2020 Virtual Annual Meeting II
SAN DIEGO, CA – (BUSINESS WIRE) – Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
 
News Coverage
Calidi’s Contribution To The Treatment Of COVID-19
In A Short Time, The Novel Coronavirus Disease (COVID-19) Has Destructively Impacted Both The People…
 
Press Release
Stem Cells for COVID-19 | PSC Teams Up with Calidi Biotherapeutics
Recently, Personalized Stem Cells (PSC) was asked by the White House Task Force to apply…
 
Press Release
Calidi Biotherapeutics Announces Appointment of Dr. George Peoples, a Prominent Immuno-Oncology Expert, to its Scientific and Medical Advisory Board
SAN DIEGO– (BUSINESS WIRE)– Calidi Biotherapeutics, Inc. (“Calidi”), a clinical‐stage biotechnology company at the forefront…
 
Press Release
Calidi Biotherapeutics Announces Appointment of Biotech Veteran Heehyoung Lee to Board of Directors
SAN DIEGO– (BUSINESS WIRE)– Calidi Biotherapeutics, Inc. (“Calidi”), a clinical‐stage biotechnology company at the forefront…